Introduction (revised)
'Patient choice' has been increasingly prioritised in UK health policies over the past decade.
Yet the very concept of patient choice is contested and used in different ways across academic, political and policy literatures [1] . Even within the NHS, patient choice may mean very different things. The NHS Choice Framework [2] , for example, outlines specific markers of choice, such as a patient's choice of location of care and of the clinician they see.
In contrast, other NHS policies emphasise choice in the context of the patient's right to decline treatment and to be involved in choosing test or treatment options [3] . For instance, a 2010 Government White Paper sets out a "vision of an NHS… where 'no decision about me, without me' is the norm" [4] . Likewise, the General Medical Council (GMC, the regulatory body which controls the training and accreditation of doctors in the UK) has declared that practitioners should maximise patients' opportunities and ability to make decisions for themselves [5] . Recently, the NHS 2014 Five Year Forward View announced that "empowering patients" is a key goal, with choice seen as central to achieving this outcome [6] . The issue of choice has been particularly highlighted in the management of chronic conditions (which make up a high proportion of neurological disorders), where patients often understand their diseases as well as, or better than, health professionals [7] .
'Patient choice' in the NHS is, then, multi-faceted. Not only does the focus vary (i.e. choice about what?), but research in this area has used diverse definitions and measures, with 'choice' often embedded within broader concepts such as 'patient-centred care', 'patient empowerment', 'patient involvement' or 'shared decision-making' [8] [9] [10] [11] . Moreover, despite the widespread claim -within the NHS and beyond -that good practice entails a more 'shared' (as opposed to a more 'paternalist') approach, the empirical literature offers far less consensus. For instance, only some studies investigating the association between measures of patient satisfaction and shared decision-making (SDM) have found a positive correlation [12] ,, with some research suggesting that this depends on the extent to which patients have a preference for autonomy [13] . A systematic review of the use of decision aids "designed to help people make specific and deliberative choices among options" found that they improved patients' knowledge of treatment options and their condition, but seemed to have "no effect on satisfaction with decision-making, anxiety and health outcomes" ( [12] p. 220). In contrast, a 2001 Cochrane systematic review found that interventions designed to increase patientcentredness generally succeeded in increasing patient satisfaction [14] . However, the same review found that these interventions did not necessarily produce positive health outcomes, with some studies showing "clear negative effects" (cited in [15] , p. . This may reflect differences across demographic subgroups and patients' presenting complaints. For instance, a review of SDM in oncology concluded that, overall SDM is associated with better outcomes and greater patient satisfaction, however there may be variability across patient groups and cancer types with respect to how involved patients want to be in decision-making processes [16] .
One of the few studies to focus explicitly on choice in the NHS [17] found that patients distinguished both between having a choice and making one, and between the appearance of choice and substantive choice. Crucially, while patients valued having a (meaningful) choice, they often reported not wanting to make the final decision. In addition to this, the importance of personal 'choice' has varied cultural and social constructions. In some cultures choice is conceptualised as essential to autonomy and fundamental to well-being [18] , while in others it may be less valued as a contributor to happiness [19] . This type of difference may make it difficult to draw general conclusions relating to choice where patients are culturally and ethnically diverse. The acknowledgment of variability amongst patients and types of choices complicates the argument that offering 'more choice' is necessarily better for all; arguably, the rights of patients to opt out of greater involvement in decision-making ought to be treated with as much respect as those of patients whose desires and values are in line with current policies on patient choice [20] .
In an attempt to address some of these issues, we previously conducted a large, prospective conversation analytic study which was primarily designed to determine whether and how choice (regarding treatments and investigations) is implemented in two outpatient neurology settings [21] . The current study further explores these data, to try and assess how often clinicians offer such choice during consultations and how frequently neurology patients perceive it as having been offered. Secondly, we measure the degree to which patients actually value being offered choice by clinicians, by assessing the influence that the perception of such choice has on patient satisfaction. In our analyses we consider the effects of neurologists' certainty about the diagnosis, agreement with the patient (eg. about choice), and the extent to which neurologists consider the presenting symptoms 'medically explained' on patients' satisfaction with their interaction with the doctor, because these features have been found to correlate with patient satisfaction with decision-making or satisfaction more generally in some previous studies [22] [23] [24] [25] .
METHODS

Participants
This prospective, multicentre study was conducted in neurology outpatient clinics at the Southern General Hospital in Glasgow and the Royal Hallamshire Hospital in Sheffield. All neurologists at the two sites were invited to participate (20 in Sheffield, 23 in Glasgow).
Consecutive new and follow-up patients attending outpatient appointments between February and June 2012 in Glasgow, and April and September 2012 in Sheffield, with one of 14 participating neurologists were approached. Out of all patients informed about the study, 223 (66%) agreed to take part. Most patients (97.2% in Sheffield, 70.2% in Glasgow) were recruited in subspeciality rather than general neurology clinics (MS, epilepsy, neuromuscular, headache, neuro-oncology). All participants were 16 years or older. Only patients with capacity to give written informed consent and the ability to complete the post-interview questionnaires unaided were included.
Data and Procedure
The present data were collected as part of a larger study involving audio or video recording of consultations. Patients' demographic characteristics were recorded in a Background Information questionnaire. As well as asking about age, gender and ethnicity, patients were also asked about their current employment status, and their highest qualifications. Ethnicity was recoded into two groups: White British and Other. Education was recoded from an 8 category variable to a dichotomous variable, in which all patients were classified as either having post-school qualifications or not. The employment variable employed distinguishes between those who are currently in work, and those who are not. A further dummy variable codes for patients who are on leave or out of work due to disability or sickness, and those who are not.
Post-appointment questionnaires were also completed by both neurologists and patients immediately after the clinical encounter. The questionnaire for neurologists asked whether they had offered 'a choice about treatment or further management' (to which they could answer yes or no) and 'to what extent are this patient's symptoms explained by a medical/neurological disorder (for which they could choose between 'completely / largely explained', 'partly explained / partly unexplained' and 'completely / largely unexplained').
They were also asked 'how certain are you of the diagnosis', which they rated on a ten point scale ranging from very uncertain (1) to very certain (10).
The patient questionnaires asked patients to state whether or not they had been offered "choice about any tests or treatment you might have or the next step in the management of your condition", and included the Medical Interview Satisfaction Scale-21 (MISS-21). A variable that described whether patients and doctors agreed whether choice had been offered was derived. The categories of this variable were 'Agree choice' (i.e. both doctor and patient agree a choice was offered), 'Agree no choice', 'Patient yes, doctor no' (i.e. the patient believed a choice was offered but the doctor didn't) and 'Patient no, doctor yes'. Details about the characteristics and distributions of the above variables can be seen in Tables 1 and   2 .
Measures
The MISS-21, developed from the United States MISS-29 measure, has been validated for use in UK patient populations [26] . It is a well-established 21-item self-report tool, which uses provider-patient interactions as an index of quality and patients' perceptions and attitudes regarding their consultations [27] . Respondents rate items on a seven-point Likert scale ranging from 'very strongly disagree' to 'very strongly agree'. Previous Factor analyses conducted using MISS-21 data have identified four subscales within this scale, which have been shown to represent discrete but overlapping aspects of satisfaction [26] .
These four subscales have been labelled 'distress-relief', 'communication comfort', 'rapport' and 'compliance intent'. The MISS-21 has been found to have satisfactory internal reliability (Cronbach's alpha values cited as between 0.67 and 0.92 for subscales) and scores have been found positively to correlate with satisfaction with previous appointments [26] .
Statistical Analysis
In view of the fact that the MISS-21 had not previously been used in neurology clinics, we initially carried out a factor analysis (principal components extraction with promax rotation) on the items captured by the MISS-21. A cut-off point of 0.5 was chosen to determine significant loading of particular items onto factors [28] (Table 3 .)
The relationships between the MISS-21, its factors, and the range of clinical and interactional variables shown in Tables 1 and 2 were examined using Pearson correlation coefficients for continuous variables and ANOVA for categorical variables (see Tables 4a and 4b ). All of the clinical, demographic or interactional factors showing an association (at the 0.2 level) with overall patient satisfaction were subsequently entered into three multiple regression models to assess their contribution to the overall MISS-21 score and to its two most important subscores (see Table 5 ).
Some individuals did not respond to all items on each questionnaire. For the purpose of analysing overall MISS-21 scores, missing values were replaced using median replacement if less than 10% of responses were missing from a particular patient. Replies with 10% or more of missing data were discounted. For other variables, listwise deletion was employed to deal with missing data. Information on the distribution of missing data can be seen in Table 1 . Table 1 shows the demographic breakdown of the sample. While participants recruited in Glasgow were significantly younger and more likely not to be working because of illness, we could not discern any clinical or demographic differences between the patients at the two different sites that suggested it would not be appropriate to combine the datasets for the analyses conducted in this study.
RESULTS
Sample characteristics
Choice
Frequency of choice
Patients perceived that they were given choice following 71.8% of encounters, whilst neurologists stated they had offered choice after 67.9% of encounters. Patients' perceptions of choice were not associated with age, gender, ethnicity, educational achievements, employment status, appointment type (new or follow-up), whether or not they were accompanied, duration of the appointment, the clinician's certainty in the diagnosis, or the clinician's gender. However, patients who attended a general neurology clinic were more likely to perceive choice being offered than those who attended a subspecialist appointment (p=0.004, Chi-Square=9.895). Neurologists' reports of whether they had offered choice were not associated with any of the demographic or clinical factors listed above. However, univariate analysis showed that offering choice was significantly associated with greater selfreported diagnostic certainty [certainty level 8.7 (SD 1.5) vs. 8.0 (SD 2.2), p=0.006, (t=2.782)]. Figure 1 shows the extent of doctor-patient agreement over whether choice was offered. Just over 50% of consultations were characterized as involving patient choice by both doctor and patient. Patients and clinicians disagreed after 32% of encounters about whether or not choice had featured in the appointment. An interrater reliability analysis using the Kappa statistic was performed to determine consistency between patients and doctors. The interrater reliability for patients and doctors was found to be Kappa = 0.24 (p =.001). While this shows a significant link between patient and doctor, a Kappa statistic between .21 and .4 indicates only a 'fair' level of agreement [29] . Figure 1 here please*
Agreement about presence of choice
*Insert
Patient Satisfaction
Factor Analysis
The factor analysis in this study generated four factors. Table 2 shows the loading of the items on each of the four factors (three items on the MISS-21 did not contribute to any of the four factors identified). Two of the factors were very similar to the 'rapport' and 'distress relief' subscales identified in previous factor analyses of the MISS-21 [8] . Therefore, we also labelled these factors 'rapport' and 'distress relief'. The remaining two subscales differed from those identified in previous research, and explained less variance in the model, so were not carried forward for further investigation. Reliability testing of the items loading onto the 'rapport' and 'distress relief' factors showed both the retained subscales had high internal reliability (Cronbach's alpha of 0.937 and 0.873 respectively). Tables 4a and 4b show the results of analyses examining the relationships between patient satisfaction as the dependent variable, and a number of other demographic, clinical and interactional variables, as well as variables measuring choice, as independent variables. Satisfaction was greater in the Sheffield sample, when doctors had greater diagnostic certainty, and when symptoms were considered 'medically explained'. There were no significant correlations between satisfaction and patient's age, gender or employment status, and the type of appointment (new versus follow-up). Satisfaction scores were not related to whether or not patients perceived that they had been offered choice and or whether clinicians believed that they had offered choice. Satisfaction scores were also unrelated to the multicategory predictor describing whether or not patient and doctors agreed that choice had been offered. However, patient satisfaction was greater when neurologists and patients agreed that choice had not been offered, compared to all other options (F(1,172)=3.853, p=0.05). Table 5 shows the results of the three OLS Regression models that show the extent to which different variables explain variance in the 'rapport' and 'distress relief' subscales, as well as in MISS-21 scores as a whole. As well as replicating the bivariate finding that scores in Sheffield were significantly higher, this analysis also shows that when a clinician believed that symptoms were medically explained, this had a significant positive impact on patients' ratings of 'rapport', and their overall MISS-21 score. It is worth noting that if the three category 'symptoms' variable is treated as continuous, or dichotomised to distinguish between 'unexplained' and 'partly explained / unexplained' (results not shown here) then all three models show a significant association between 'symptoms' better explained by neurological disorder and greater patient satisfaction. These models also show that when clinicians were certain of the diagnosis, scores on the 'distress-relief' subscale were significantly higher. The bivariate finding that patient satisfaction was higher when patients and doctors both agreed choice had not been offered was not replicated in the multivariate analysis.
Bivariate analyses
Multivariate analyses
DISCUSSION AND CONCLUSION
Discussion
Are patients offered choice?
Our findings suggest that the neurologists included in this study have embraced NHS and GMC guidance on engaging patients in clinical decision-making processes and that patient choice features in over two thirds of clinical encounters in Glasgow and Sheffield neurology clinics, irrespective of demographic factors such as age and educational level. The fact that choice was perceived more commonly by patients who had attended general rather than subspecialist neurology appointments, and when clinicians reported greater certainty about their diagnosis, suggests that the reasons choice featured in interactions were more likely to be clinical than related to personal background or demographic factors.
Having said this, it is striking that doctors and patients disagreed after 32% of appointments on whether choice had been given choice or not. This finding is in line with previous work on patients' and clinicians' perceptions of clinical encounters [30] . It suggests that it is difficult to objectify the concept of 'patient choice' in interaction. What is more, it demonstrates that it is not entirely straightforward for clinicians to provide patients with choice in a way that patients perceive as such. Preliminary qualitative work has provided some reasons why clinicians' and patients' views may diverge: for instance clinicians may use the "machinery" of choice (including a list of options followed by a question eliciting the patient's view) whilst heavily 'loading' the list and actually making a strong recommendation, rather than offering a choice between evenly 'balanced' alternatives [31] .
Does choice lead to higher patient satisfaction?
In this study we found no evidence that the provision or perception of choice increases patients' satisfaction with the clinical encounter or the clinician. Indeed, initial analyses appeared to indicate that those consultations in which doctors and patients agreed that choice had not been provided were associated with higher overall satisfaction ratings than all other encounters (although this finding was not replicated in the multivariate analysis, when whether or not patient symptoms were medically explained was taken into account). Our preliminary Conversation Analytic study [21] , in which five different major types of 'no choice' consultations were identified, could be of relevance here. The five different types were consultations in which: 1) No treatment was required because there was no medical problem; 2) nothing was offered because the medical problem was not neurological; 3) nothing needed to be done because no treatment was required for the neurological problem at present; 4) nothing needed to be done because treatment for the neurological problem had been exhausted; and 5) no change was needed because the treatment for the neurological problem was working. Analysis of these interactions suggests that decisions were actually made during these clinic appointments, but it seems that "no action" or "no change" decisions are often not recognised as a matter of choice by either party involved in the interaction.
Nevertheless, it is worth noting that encounters in which such decisions were made left patients feeling more satisfied than those involving decisions about changes.
The fact that 'choice' had no positive impact on patient satisfaction cannot be explained by a lack of sensitivity on the part of the MISS-21 instrument. While there is no universally accepted definition of 'satisfaction', measures like the MISS-21 are thought to capture an important dimension of the quality of care [32] . For instance, one study has shown that higher overall satisfaction ratings as measured by the MISS-21 were positively associated with subsequent symptom resolution [33] . In our study, in addition to the observation that patients expressed greater satisfaction after 'agreed no choice' encounters, patients reported greater satisfaction on the 'distress-relief' scale when the clinician was more certain about the diagnosis, providing some additional support for the sensitivity of the scale. Patients whose symptoms were considered 'medically explained' expressed greater satisfaction overall, as well as on the 'rapport' subscale, than those whose symptoms were thought 'medically unexplained'. This finding may reflect the fact that patients with 'medically In our study, in addition to the observation that patients expressed greater satisfaction after 'agreed no choice' encounters, patients reported greater satisfaction on the 'distress-relief' scale when the clinician was more certain about the diagnosis. Patients whose symptoms were considered 'medically explained' expressed greater satisfaction overall, as well as on the 'rapport' subscale, than those whose symptoms were thought 'medically unexplained'. It has been argued that the 'rapport' subscale of the MISS-21 has particular clinical relevance because studies using other measures have demonstrated that interactions in which physicians are perceived as being empathic, reassuring and as showing positive affect are associated with better patient outcomes [34] [35] [36] [37] [38] . This subscale has previously been used in Conversation Analytic (CA) research and been shown to be sensitive to interactional features in primary care consultations [39] . In keeping with the findings of our study, CA studies have shown that consultations with patients whose symptoms are 'medically unexplained' are particularly challenging for both parties involved in the interaction [40 41 ].
Limitations of the study
Our study has a number of limitations. Although we captured the communication practice of Whilst it has been argued that patient involvement in decision-making is particularly important in such patient groups [7] , it may be that patient satisfaction is influenced by other factors if presentations are related to more acute disorders. Our findings may also have been affected by a lack of clarity of what we meant by the term 'choice' in the questionnaires completed by patients and doctors.
Conclusions
Despite these limitations, our study demonstrates that, in line with the recommendations of the UK Department of Health and the General Medical Council, 'patient choice' features in the majority of clinical encounters in neurology outpatient appointments. However, doctors and patients often disagree about whether choice featured in the clinic interaction. There was no evidence that choice increased patient satisfaction.
Practice Implications
This study demonstrates that government policy and GMC guidance to implement patient choice are not easily realised in practice. Clinicians and their patients do not always have the same perception of what constitutes choice. Doctors need to be very explicit in their interactions if they want to be sure that the patient has understood that they are being given choice. Having said that, doctors should realise that 'choice' is not universally valued by all patients in all clinical scenarios. Importantly, the absence of 'choice' does not always indicate an absence of shared decision-making. Indeed, initial qualitative work on our dataset suggests that 'choice' might not be the defining feature of shared decision-making. Further work needs to be done to establish whether there are particular interactional scenarios in which patients value 'choice' more highly.
Patients appear to value being given a certain and medically-based diagnosis for their symptoms. In situations where this is possible, patients rate their rapport with their clinician as greater, and their overall satisfaction as higher.
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